Genentech, Inc. (NYSE: DNA) announced today that it has been named by FORTUNE Magazine as one of the "Top 100 Companies To Work For In America" for the third consecutive year. The complete list of companies will appear in the January issue of the magazine.

"We are very proud to be included in the Fortune "Top 100 Companies To Work For In America" list again," said Arthur D. Levinson, Ph.D., Genentech chairman and chief executive officer. "Since our founding, nearly 25 years ago, Genentech has recognized that its employees are key to our company's success. We strive to cultivate and maintain an environment that attracts, retains and rewards the best and brightest employees."

FORTUNE screened a broad range of companies for its list. Genentech, along with the other well-respected companies on the list, was chosen based on answers 250 random employees gave to 57 questions on the Great Place to Work Index Trust survey, conducted by the Great Place to Work Institute in San Francisco. FORTUNE also reviewed company newsletters, employee handbooks and videos.

The company's long list of benefits range from a six-week paid sabbatical after six years and an adoption assistance program to free commuter shuttles and an on-site concierge service. Genentech also offers all its employees an employee stock purchase plan, eligibility for stock options and on-the-spot bonuses for exceptional work. Other benefits include health seminars, flexible work arrangements, a company-sponsored fitness facility and one of the largest corporate-sponsored daycare centers in the country.

Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Fourteen of the currently approved biotechnology products stem from Genentech science. Genentech markets nine biotechnology products directly in the United States. The company has headquarters in South San Francisco, California and is traded on the New York Stock Exchange under the symbol DNA.

Genentech

Genentech

More from Genentech